Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer.
$5.53 +0.04 (0.73%)
As of 05/20/2022 15:59:58 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.